Phase III extension study of VM-202 in diabetic peripheral neuropathy meets primary endpoint Oct. 8, 2019
Targeting ATP6V1A subunit in the v-ATPase complex inhibits mTORC1 signaling and activates autophagy Oct. 4, 2019
RSS